An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
Vaccines, Free Full-Text
Vaccine Supply Chain Improvements Could Pave the Way to Profitability
Stages in COVID-19 vaccine development: The Nemesis, the Hubris
PDF) Reduced immunogenicity of a live Salmonella enterica serovar
Mucosal vaccine delivery: Current state and a pediatric
Adjuvant Development NIAID: National Institute of Allergy and
NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal
World experts to gather for IVI symposium on hepatitis E – IVI
Vaccine - Wikipedia
Frontiers CAvant® WO-60 as an Effective Immunological Adjuvant
Key roles of adjuvants in modern vaccines - Document - Gale
Key roles of adjuvants in modern vaccines - Document - Gale
Key roles of adjuvants in modern vaccines - Document - Gale
Mucosal vaccines — fortifying the frontiers
Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect
